---
schema_version: "secwatch.filing_event.v1"
accession: "0001520138-24-000034"
form_type: "8-K"
ticker: "BIVI"
cik: "0001580149"
company_name: "BIOVIE INC."
filed_at: "2024-01-19T23:59:59+00:00"
generated_at: "2026-06-06T21:18:22.260643+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# BioVie files prospectus supplement for up to $25M ATM; already raised $59.4M from 8.1M shares

## Summary
- Filed prospectus supplement under new shelf registration (333-274083) for continued at-the-market sales of common stock.
- As of Jan 19, 2024, issued 8,136,058 shares under existing Sales Agreement with Cantor Fitzgerald for net proceeds of $59.4M.
- Commissions and expenses totaled ~$1.8M; new shelf effective Aug 28, 2023 replaces expiring Feb 2, 2024 shelf.
- Up to $25M aggregate offering price authorized under the new supplement.

## SEC filing metadata
- accession: 0001520138-24-000034
- form_type: 8-K
- ticker: BIVI
- cik: 0001580149
- company_name: BIOVIE INC.
- filed_at: 2024-01-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1580149/000152013824000034/0001520138-24-000034-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1580149/000152013824000034/bivi-20240119_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001520138-24-000034
- JSON: https://secwatch.observer/filing/0001520138-24-000034.json
- Plain text: https://secwatch.observer/filing/0001520138-24-000034.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.